Candida albicans plays a dynamic role in the complex ecosystem of the gut microbiota. While normally present in the gastrointestinal tract, an overgrowth of C. albicans, often referred to as intestinal candidiasis, can disrupt the balance of the gut microbiota. Factors such as a high-sugar diet, prolonged use of antibiotics, and immunosuppression can contribute to the proliferation of C. albicans in the gut. Imbalances in the gut microbiota, including an overgrowth of Candida, have been associated with various health issues, ranging from digestive problems to systemic effects on overall health. Some theories suggest a connection between gut dysbiosis and conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Maintaining a healthy gut microbiota involves dietary modifications, probiotic supplementation, and lifestyle changes. Research into the intricate interactions between Candida albicans and other microorganisms in the gut is ongoing, providing valuable insights into the potential links between gut health and various systemic conditions.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Mathematical modeling of COVID-19 dynamics in a West African context
Christabel Emaeyak James, University of Glasgow, United Kingdom
Title : Severe influenza and other related respiratory infection cases during Omicron era in Japan
Masafumi Seki, Saitama Medical University International Medical Center, Japan